← Leaderboards
Rebecca Pfeifer
Allegheny-Singer Research Institute
$639,967
Attributed
$639,967
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $293K · FY2015–17$500K$375K$250K$125K$0
'15
'16
'17
Funding mix
By agency
NIH$639,967 · 1
By mechanism
N01$639,967 · 1
Top collaborators
No co-investigators on record.
Most similar at Allegheny-Singer Research Institute
Same institution · by research overlap
- Michael Scott Halbreiner$595,727
- Garth D. Ehrlich$17,065,579
Others in their field
Top investigators on “Blood Vessels”
- Sonia M Thomas · Research Triangle Institute$353,402,726
- Tracy L Nolen · Research Triangle Institute$353,402,726
- Charles Decarli · University Of California At Davis$66,498,201
- Josef Coresh · New York University School Of Medicine$63,693,760
- Sterling C Johnson · St. Joseph'S Hospital And Medical Center$62,000,770
- Robert P Kimberly · University Of Alabama At Birmingham$56,093,149
Research focus
Blood VesselsClinical AssessmentsComputer SoftwareContractsDevicesDiagnosticDisease ProgressionFutureHemodynamicsImaging TechnologyInnovationLearningSafety TestingSupport ContractsVascular DiseasesModalityMonitorNational Heart, Lung, And Blood InstituteProduct DevelopmentPrognosticPrognostic ToolProgramsPulmonary Arterial HypertensionPulmonary Hypertension
Grant awards (3)
IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): A Study to Explore the Feasibility of using Combined Modalities to Test the Safety of CaridMEMS Device in PAH Patients$59,626
N01 · FY2017 · HL · contact PI
IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): A Study to Explore the Feasibility of using Combined Modalities to Test the Safety of CaridMEMS Device in PAH Patients$292,983
N01 · FY2016 · HL · contact PI
IGF::OT::IGF Vascular Interventions/Innovations and Therapeutic Advances (VITA): A Study to Explore the Feasibility of using Combined Modalities to Test the Safety of CaridMEMS Device in PAH Patients$287,358
N01 · FY2015 · HL · contact PI